AskTheDate.com
Back to calendar

Latigo Biotherapeutics, Inc. (LTGO) Earnings

LTGO reports earnings on Wednesday, September 2, 2026

earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.62
Actual EPS: $-3.93
Company overview
Market Cap$1.4B
PriceUSD 21.92
52-week high25.93
52-week low17.22
SectorHealth Technology
IndustryPharmaceuticals: Major
Buy me a coffee